ODZ-514

Organization name

VIDIA spol. s r.o.

SRN

CZ-MF-000036964

Manufacturer status

Active

10 warnings recorded — scroll inside the panel to see all entries.

• CW083

  EUDAMED did not publish a description for this code.
• CW105

  EUDAMED did not publish a description for this code.
• CW167

  EUDAMED did not publish a description for this code.
• CW422

  EUDAMED did not publish a description for this code.
• CW306

  EUDAMED did not publish a description for this code.
• CW272

  EUDAMED did not publish a description for this code.
• CW096

  EUDAMED did not publish a description for this code.
• CW138

  EUDAMED did not publish a description for this code.
• CW313

  EUDAMED did not publish a description for this code.
• CW999

  P501 Odstraňte obsah/obal podle místních předpisů.

Primary placement in Czechia; available across 1 country total.

Trade name

not provided

UDI-DI code

28594036045143

Basic UDI-DI

B-28594036045143

Reference / catalog number

ODZ-514

Issuing entity

GS1

Risk category

IVDD — General

Applicable legislation

IVDD [Directive 98/79/EC on in vitro diagnostic medical devices]

Status

On the market

Quantity

1

Additional product description

Souprava je určena pro profesionální použití pro kvalitativní, semikvantitativní a kvantitativní detekci specifických protilátek třídy IgA proti antigenu Aspergillus fumigatus v lidském séru a plazmě. Test se používá pro diagnostiku mykotických infekcí a dalších onemocnění způsobených A. fumigatus.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification

European Medical Device Nomenclature — the EU product classification assigned to this device.

• W0105060301ASPERGILLUS